BELLUS Health Inc. develops drugs for rare diseases, including conditions that affect the kidneys. The Company's main operations are in a Phase III Confirmatory Study for the treatment of AA amyloidosis. BELLUS is also developing treatments for sarcoidosis and hemolytic uremic syndrome.
275 Armand-Frappier Boulevard
Laval, QC H7V 4A7